CODA participates in various types of research including surveys, observational studies and clinical trials that may involve medications – all have different eligibility criteria.

All participants go through the informed consent process which provides them with clear explanations of the rights and risks prior to joining a research study.

To learn more about current studies:
Email: research@codainc.org

Some of our studies provide medications at no cost

You will be compensated for participating

Your personal information is confidential

We are currently recruiting for the following studies:

Adjunctive Cannabidiol for Recovery from Opioid Study (ACROS)

Are you currently being treated for your Opioid Use Disorder with Methadone or Buprenorphine but still having cravings? Are you interested in participating in a research study? If so, please reach out by email research@codainc.org, call or text at 503-421-5433, or use the “Contact Us” button to the right. You will be compensated for your time!

CODA, Inc. is working with the National Institute on Drug Abuse (NIDA) and the Icahn School of Medicine at Mount Sinai on a research study. The long-term goal of the project is to determine whether Cannabidiol (CBD) can reduce craving and relapse in individuals with opioid use disorder (OUD). If eligible, you would receive a twice daily dose of the active medication or a placebo at no cost to you over a 24-week period.